BAY-Y 3118 is primarily utilized in the field of pharmaceutical research, particularly in the development of anti-inflammatory and analgesic medications. Its application focuses on inhibiting specific enzymes or pathways involved in inflammation and pain, making it a potential candidate for treating conditions like arthritis or chronic pain disorders. Researchers also explore its use in studying cellular mechanisms related to inflammation, contributing to the advancement of targeted therapies. Additionally, its role in preclinical studies helps in understanding drug efficacy and safety profiles before progressing to clinical trials.